AKTIS ONCOLOGY TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

/PRNewswire/ — Aktis Oncology, a clinical stage biotechnology company discovering and developing novel targeted alpha radiopharmaceuticals to treat a broad…Read More